In the portfolio
APH · Amphenol Corporation
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 16 October 2026; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A weekly close below $76, under the support range that held the June–August trading range on the split-adjusted series. A third-quarter 2026 sales report below the $9.3 billion guidance floor would also break the case.
Open pick Medium conviction, opened at $79.35. Kill line at open: $76.00 (weekly close); graded by at the latest.
In the portfolio Since : −0.4%. See the portfolio.
Catalyst (in 11 days)
How picks are graded →The thesis
Amphenol Corporation's interconnect products for artificial-intelligence (AI) data centers have lifted the shares to $85.32, 3.7% below the 52-week high of $88.62, and the 28 October 2026 third-quarter report settles whether July's order surge became sales. On 29 July 2026 the company reported $10.7 billion of second-quarter orders against $8.8 billion of sales, a 1.23:1 book-to-bill ratio (orders divided by sales), and guided third-quarter sales to $9.3–9.4 billion.
The narrative is maturing: the story is well known, and three brokers raised price targets between 6 October 2026 and 8 October 2026 ahead of the report. Goldman Sachs raised its target to $116, UBS to $105 and Citigroup to $112, all with Buy ratings (Benzinga headlines). The adjusted close of $85.32 on 8 October 2026 is above the $84.59 recovery level that the shares failed to reach on 25 September 2026, when they closed at $84.09.
Bullish and bearish views on Amphenol Corporation
The bull case on Amphenol Corporation (APH), in brief: Orders give revenue visibility. The bear case: Acquisitions flatter reported growth.
Bull case
- Orders give revenue visibility. Amphenol reported second-quarter orders of $10.7 billion on 29 July 2026, well above $8.8 billion of sales. Third-quarter sales at or above the $9.3 billion guidance floor would show the backlog converting.
- Organic growth is strong. Second-quarter sales rose 55% in dollars and 30% organically, with management describing exceptional organic growth in IT datacom (company release, 29 July 2026).
- Analysts are raising targets. Goldman Sachs ($116, 6 October 2026), UBS ($105, 7 October 2026) and Citigroup ($112, 8 October 2026) each maintained Buy and lifted targets. Bernstein initiated at Outperform with a $99 target on 23 September 2026. All four targets sit above the $85.32 close.
- Price momentum has returned. The three-month price change was +9.6% on 8 October 2026, against +1.2% on 25 September 2026. The 52-week high moved up from $88.02 to $88.62 over the same stretch (adjusted daily closes).
Bear case
- Acquisitions flatter reported growth. Dollar sales growth of 55% compares with 30% organic growth in the second quarter, and the company expected the acquired CommScope business to add $4.6 billion of 2026 sales (release, 29 July 2026). Slower organic growth at the 28 October 2026 report would weaken the AI-demand reading.
- Tariff recovery lifts the comparison. The second-quarter operating income included an $80 million net tariff-recovery benefit, and third-quarter guidance excluded further recoveries (release, 29 July 2026). The 29.8% adjusted operating margin may not repeat.
- The shares are stretched into the print. The 14-day relative strength index (RSI), a momentum gauge on a 0–100 scale, was 74.0 on 8 October 2026, up from 53.2 on 25 September 2026. The earnings report is 20 days away, so the target raises have arrived before the result.
- Market breadth is narrow. A Motley Fool headline on 6 October 2026 noted the S&P 500 at record highs with only 3% of its stocks participating, so a pullback in AI leaders would be felt here.
Price setup
The adjusted close on 8 October 2026 was $85.32. The 52-week high is $88.62, 3.7% above the close. The three-month price change is +9.6% and the 14-day RSI is 74.0, which is above the 70 level usually read as stretched.
The $84.59 level, which capped the shares on 25 September 2026, is now below the price. The lower support is $76, the level that held the June–August trading range on the split-adjusted series. The two-for-one split on 3 September 2026 means pre-split quotes need halving to compare.
Crowding evidence that can be observed: heavy analyst activity in a three-session span, an RSI above 70, a close within 4% of the 52-week high and an earnings date 20 days out. No SEC Form 4 insider filings are listed for the period.
Catalysts, next 30 days
- 28 October 2026 — Third-quarter 2026 earnings report. Sales are tested against the $9.3–9.4 billion guidance range, and the order book is tested against the 1.23:1 ratio set in July. Organic growth, the operating margin and the fourth-quarter outlook will show whether the 6 October to 8 October 2026 target raises were justified.
No other company-dated event is listed inside the next 30 days.
What would change the view
The case breaks if third-quarter 2026 sales come in below the $9.3 billion guidance floor, or if organic growth falls well short of the second quarter's 30%. Either would show that the $10.7 billion of orders did not convert on schedule.
On price, a weekly close below $76 would lose the support that held the June–August range. A drop back below $84.59 before 28 October 2026, with the RSI unwinding from 74.0, would show the recovery did not hold. A report with sales in the guided range and organic growth near 30% would support the case further.
What it trades with
Amphenol's results depend on spending by AI data-center builders and on demand for IT datacom connectors, so it tends to move with other AI-infrastructure suppliers. The acquired CommScope business adds a communications-network component to 2026 sales. Because the S&P 500 was at record highs on 6 October 2026 with narrow participation, the shares are exposed to a broader market pullback as well as to company news.
Notes
- Amphenol's two-for-one stock split began trading ex-split on 3 September 2026; per-share figures and price levels before that date are not directly comparable with later quotes.
- Reported growth includes the acquired CommScope business, which the company expected to add $4.6 billion of 2026 sales, so dollar growth overstates organic growth.
Related · shared themes
AMD
Advanced Micro Devices, Inc.
Advanced Micro Devices still reports AI chip demand ahead of supply, backed by TSMC's record 15 October 2026 guide, but its shares fell with chips on rate and AI-financing fears; the 3 November 2026 third-quarter report settles the case against the $13.0 billion revenue guide and OpenAI's fourth-quarter Helios start.
GOOGL
Alphabet Inc.
Alphabet's Google Cloud, growing 82% with a $514 billion backlog and Anthropic as its largest outside chip customer, carries the case for the shares against 2026 capex of up to $205 billion. The third-quarter report expected around 28 October 2026 shows whether cloud growth keeps pace with that spending.
NVDA
NVIDIA Corporation
NVIDIA's data-center demand still looks on track for its $108.0 billion October-quarter outlook after TSMC guided fourth-quarter revenue to $52.3–54.3 billion, but customer funding stress is rising. Microsoft's 28 October 2026 results are the next test and NVIDIA's 17 November 2026 report settles the case.
CSCO
Cisco Systems, Inc.
Cisco Systems' AI-networking orders point to faster fiscal 2027 revenue, with Microsoft now in production on its P200 systems; the first-quarter report expected around 11 November 2026 shows whether $9.3 billion of AI orders become revenue at a 65–66% adjusted gross margin.